Govt to buy 4.5 crore doses of Covishield from Serum Institute

New Delhi:  The government has committed to buy from the Serum Institute further 4.5 crore doses of Oxford COVID-19 vaccine, Covishield, at a price of Rs 200 per shot plus applicable taxes by April, in addition to a firm order given to the company for 1.1 crore doses. Fights have started ferrying the vaccines to different cities from Pune from Tuesday morning. According to the purchase order placed on Monday, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210. Also Read – Gold Prices Today January 12, 2021: Yellow Metal Rates Fall Again, Down Almost Rs 7,000 From Record Highs

The HLL Lifecare Limited, a public sector undertaking, issued the supply orders on behalf of the Union Health Ministry on Monday. Also Read – SCO vs HUR Dream11 Team Predictions, Hints And Tips For BBL 2020-21 Match 37: Captain, Fantasy Playing Tips, Probable XIs For Today’s Perth Scorchers vs Hobart Hurricanes T20 at Perth Stadium 1:45 PM IST January 12 Tuesday

The first order of 1.1 crore doses? of Covishield will be worth Rs 231 crore, while the total amount including the commitment for 4.5 crore doses will amount to an estimated Rs 1,176 crore at current rates, according to sources. Also Read – Shocking! Woman Murdered by Neighbour’s Dog Trainer in Jaipur

“It is further informed that there is a commitment to purchase further 450 lakh doses from Serum Institute of India Pvt Limited, a manufacturer ?(through subsidiary Serum Institute of Life Sciences Pvt Limited) at Rs 200 per dose plus GST if applicable by April 2021,” the letter of comfort signed by Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs at Serum Institute of India (SII) and R S Manku, Vice President (Govt Business) stated.

“This is in continuation to the supply order dated January 11 for supply of 1.1 crore doses of Covishield vaccine as approved by DCGI vide permission dated January 3 for restricted use in emergency situation,” it stated.?

The government on Monday also placed an order to Bharat Biotech for 55 lakh doses of indigenously developed Covaxin costing Rs 162 crore.?

India had recently approved two vaccines, Oxford's Covishield manufactured by SII in the country and Bharat Biotech's Covaxin, for restricted emergency use.

The country will launch its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world's largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers.

According to the COVID-19 Vaccine Operational Guidelines, the shots will be offered first to an estimated one crore healthcare workers, and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities based on evolving pandemic situation.

PTI